The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 46,578 | 4,043,212 | SH | SOLE | 4,043,212 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 5,417 | 834,689 | SH | SOLE | 834,689 | 0 | 0 | ||
| GENWORTH FINL INC | COM CL A | 37247D106 | 9,228 | 2,097,335 | SH | SOLE | 2,097,335 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 19,078 | 465,664 | SH | SOLE | 465,664 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 14,541 | 112,689 | SH | SOLE | 112,689 | 0 | 0 | ||
| THIRD PT REINS LTD | COM | G8827U100 | 2,390 | 227,185 | SH | SOLE | 227,185 | 0 | 0 | ||
| TRONOX HOLDINGS PLC | SHS | G9087Q102 | 149 | 13,055 | SH | SOLE | 13,055 | 0 | 0 | ||